Enalapril Maleate and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Enalapril Maleate and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | enalapril maleate and hydrochlorothiazide |
| SUBSTANCE NAME: | ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2001-09-19 |
| END MARKETING DATE: | 0000-00-00 |
Enalapril Maleate and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Enalapril Maleate and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2001-09-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0712_fc29bbe8-c7db-4343-90af-88d68e408901 |
| PRODUCT NDC: | 0378-0712 |
| APPLICATION NUMBER: | ANDA075624 |
Other ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
